Product NDC: | 43063-431 |
Proprietary Name: | Loperamide Hydrochloride |
Non Proprietary Name: | loperamide hydrochloride |
Active Ingredient(s): | 2 mg/1 & nbsp; loperamide hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 43063-431 |
Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA072741 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121012 |
Package NDC: | 43063-431-15 |
Package Description: | 15 CAPSULE in 1 BOTTLE, PLASTIC (43063-431-15) |
NDC Code | 43063-431-15 |
Proprietary Name | Loperamide Hydrochloride |
Package Description | 15 CAPSULE in 1 BOTTLE, PLASTIC (43063-431-15) |
Product NDC | 43063-431 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | loperamide hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20121012 |
Marketing Category Name | ANDA |
Labeler Name | PD-Rx Pharmaceuticals, Inc. |
Substance Name | LOPERAMIDE HYDROCHLORIDE |
Strength Number | 2 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Opioid Agonist [EPC],Opioid Agonists [MoA] |